ASCO shared on LinkedIn:

“Last call! Join us on Monday, May 6, for The TAPUR Study Virtual Grand Rounds.

The TAPUR Study is an ongoing clinical trial conducted by ASCO that examines the potential of using targeted therapies outside of their approved use to benefit patients with later-stage cancer and lead to increased options for personalized therapies.

• When: May 6 at 2:00 PM ET
• Where: Online
• Who: Open to all members of the oncology community

Featured speakers include:

• Dr. Richard Schilsky, TAPUR Study Principal Investigator
• Dr. Jens Rueter, Medical Director of the Maine Cancer Genomics Initiative
• Janet Freeman-Daily, Lung cancer patient and advocate; President of The ROS1ders“

Source: ASCO/LinkedIn